Fig. 1From: miR-140-3p is a potential differential biomarker in benign phyllodes tumors and fibroadenoma of the breastStudy design flowchart. Human miRNA-Seq was used for screening candidate miRNAs, and qRT-PCR was used for validationBack to article page